Anti-CLC4G/ CLEC4G/ DTTR431 monoclonal antibody

Anti-CLC4G/ CLEC4G/ DTTR431 antibody for FACS & in-vivo assay

Target products collectionGo to CLEC4G/CLEC4G products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0299-Ab-1/ GM-Tg-hg-MP0299-Ab-2Anti-Human CLEC4G monoclonal antibodyHuman
GM-Tg-rg-MP0299-Ab-1/ GM-Tg-rg-MP0299-Ab-2Anti-Rat CLEC4G monoclonal antibodyRat
GM-Tg-mg-MP0299-Ab-1/ GM-Tg-mg-MP0299-Ab-2Anti-Mouse CLEC4G monoclonal antibodyMouse
GM-Tg-cynog-MP0299-Ab-1/ GM-Tg-cynog-MP0299-Ab-2Anti-Cynomolgus/ Rhesus macaque CLEC4G monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0299-Ab-1/ GM-Tg-felg-MP0299-Ab-2Anti-Feline CLEC4G monoclonal antibodyFeline
GM-Tg-cang-MP0299-Ab-1/ GM-Tg-cang-MP0299-Ab-2Anti-Canine CLEC4G monoclonal antibodyCanine
GM-Tg-bovg-MP0299-Ab-1/ GM-Tg-bovg-MP0299-Ab-2Anti-Bovine CLEC4G monoclonal antibodyBovine
GM-Tg-equg-MP0299-Ab-1/ GM-Tg-equg-MP0299-Ab-2Anti-Equine CLEC4G monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0299-Ab-1/ GM-Tg-hg-MP0299-Ab-2; GM-Tg-rg-MP0299-Ab-1/ GM-Tg-rg-MP0299-Ab-2;
GM-Tg-mg-MP0299-Ab-1/ GM-Tg-mg-MP0299-Ab-2; GM-Tg-cynog-MP0299-Ab-1/ GM-Tg-cynog-MP0299-Ab-2;
GM-Tg-felg-MP0299-Ab-1/ GM-Tg-felg-MP0299-Ab-2; GM-Tg-cang-MP0299-Ab-1/ GM-Tg-cang-MP0299-Ab-2;
GM-Tg-bovg-MP0299-Ab-1/ GM-Tg-bovg-MP0299-Ab-2; GM-Tg-equg-MP0299-Ab-1/ GM-Tg-equg-MP0299-Ab-2
Products NameAnti-CLEC4G monoclonal antibody
Formatmab
Target NameCLEC4G
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CLEC4G benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CLC4G/ CLEC4G/ DTTR431 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0299
    Target NameCLEC4G
    Gene ID339390,75863,689004,704872,484999,101096037,507332
    Gene Symbol and Synonyms4930572L20Rik,CLEC4G,DTTR431,LP2698,LSECtin,RGD1562320,UNQ431
    Uniprot AccessionQ6UXB4
    Uniprot Entry NameCLC4G_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182566
    Target ClassificationN/A

    The target: CLEC4G, gene name: CLEC4G, also named as DTTR431, LP2698, LSECtin, UNQ431. This gene encodes a glycan-binding receptor and member of the C-type lectin family which plays a role in the immune response. C-type lectin receptors are pattern recognition receptors located on immune cells that play a role in the recognition and uptake of both self and non-self glycoproteins as well as mediating cell adhesion, glycoprotein clearance, and cell signaling functions. This gene's protein binds complex-type N-glycans of the viral envelope proteins of Ebola virus, West Nile filovirus, and SARS coronavirus, but not HIV or hepatitis C virus. In mouse, this protein has been shown to recognize activated T-cells and to negatively regulate T-cell receptor-mediated signalling. It also acts as a novel, liver-specific regulator of NK cell-mediated immunity in mouse. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.